For many people, they are unaware of what certain organizations do for their state. Autism Speaks is one of them. There are many Ohioans who believe that Autism Speaks does not give back to the Ohio community and that is completely wrong. I recently attended the Walk Now for Autism Speaks Kick-Off event in Columbus and received this handout so that I could share information with others people. The information listed below is specific to Ohio, but if you would like to know what Autism Speaks does for your state visit their website at autismspeaks.org
The mission of Autism Speaks is dedicated to increase awareness, research, advocacy and family services for all who struggle with autism spectrum disorders.
Autism Speaks has committed over $98 million in grants to support 773 promising research projects and fellowships into the causes and treatments of autism. The investment in these research grants alone has been leveraged into nearly $153 million in NIH and other funding. In Ohio, 14 projects representing over $2.6 million in investments have been funded:
Case Western Reserve University- Cleveland, OH
CNS pattern Formulation and the Etiology of Autism
The Engrailed-2 Mutant as a Model of Neuropathology of Autism
Cincinnati Children's Hospital Medical Center/ Research Foundation- Cincinnati, OH
Genetic Control of Mammalian Amygdalar Development
Immune Phenotypes in Autism Spectrum Disorder
Does Immune System dysfunction play a role in autism?
Genome-wide Association Study of Autism Characterized by Developmental Regression
Participating in the Autism Treatment Network (ATN). The ATN is the nation's first network of hospitals and physicians dedicated to developing a model of comprehensive medical care for children and adolescents with autism.
Cleveland State University- Cleveland, OH
A play and Joint Attention Intervention fro Preschool Teachers and Young Children with Autism
Ohio State University/Ohio State University Medical Center- Columbus, OH
Risperidone and Behavior Therapy in Children with Pervasive Developmental Disorder: Long Term Follow-up
Neuronal Nicotonic Receptor Modulation in the Treatment of Autism: A Pilot Trial of Mecamylamine
Pharmacological Modulation of Functional Connectivity in Autism Spectrum Disorder
Participating in the Clincal Trial Network (CTN) study on Fluoxetine in Autism (SOFIA). THe CTN focuses on translational research, the critical step necessary to transfer findings from the laboratory to clinical application.
The Research Institute at Nationwide Children's Hospital and the Ohio State University- Columbus, OH
Autism Genome Project (AGP) Data Coordinating Center
The Autism Simplex Consortium (TASC) Data Coordinating Center
Wright State University- Dayton, OH
Neuro-Endocrine Peptide Hormones are Implicated in Social Behavior Development: Oxytocin involvement in Autism
Cellular mechanisms controlling central oxytocinergic activity: Role in the pathophysiology of autism.
No comments:
Post a Comment